Covestor’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Sell |
9,349
-7,712
| -45% | -$103K | 0.07% | 421 |
|
|
2025
Q1 | $174K | Buy |
17,061
+15,779
| +1,231% | +$161K | 0.12% | 199 |
|
|
2024
Q4 | $20K | Buy |
1,282
+1,280
| +64,000% | +$20K | 0.01% | 1187 |
|
|
2024
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2480 |
|
|
2024
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2502 |
|
|
2024
Q1 | $0 | Sell |
2
-5
| -71% | – | ﹤0.01% | 2506 |
|
|
2023
Q4 | $0 | Buy |
7
+4
| +133% | – | ﹤0.01% | 2440 |
|
|
2023
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 2426 |
|
|
2023
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2414 |
|
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2322 |
|
|
2022
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2344 |
|
|
2022
Q3 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 2306 |
|
|
2022
Q2 | $0 | Sell |
4
-1
| -20% | – | ﹤0.01% | 2136 |
|
|
2022
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2290 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2237 |
|